Navigation Links
BioCryst To Present At 12th Annual BIO CEO & Investor Conference
Date:2/1/2010

BIRMINGHAM, Ala., Feb. 1 /PRNewswire-FirstCall/ -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that Jon P. Stonehouse, President and Chief Executive Officer of BioCryst, plans to provide a corporate summary and updates regarding its clinical programs for peramivir, forodesine and BCX4208 at the 12th Annual BIO CEO & Investor Conference in New York on February 8, 2010 at 10:30 a.m. Eastern Time.

Links to a live audio Web cast and replay of the presentation may be accessed on the BioCryst Web site at www.biocryst.com.    

About BioCryst

BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule pharmaceuticals that block key enzymes involved in infectious diseases, cancer and inflammatory diseases.  BioCryst has progressed two novel compounds into late-stage pivotal clinical trials; peramivir, an anti-viral for influenza, and forodesine, a purine nucleoside phosphorylase (PNP) inhibitor for cutaneous T-cell lymphoma (CTCL).  Utilizing crystallography and structure-based drug design, BioCryst continues to discover additional compounds and to progress others through pre-clinical and early development to address the unmet medical needs of patients and physicians.  For more information, please visit the Company's Web site at

SOURCE BioCryst Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. BioCryst to Release Third Quarter 2007 Financial Results on Thursday, November 8, 2007
2. BioCryst Pharmaceuticals to Announce First Quarter 2008 Financial Results on May 8, 2008
3. BioCryst Reports Positive Results From a Phase 2 Study of Intravenous Peramivir for Outpatient Influenza
4. BioCryst to Present at the Rodman and Renshaw 10th Annual Healthcare Conference
5. BioCryst Pharmaceuticals to Announce Fourth Quarter and Year End 2008 Financial Results on February 6, 2009
6. BioCryst to Present at the 11th Annual BIO CEO & Investor Conference
7. BioCryst Pharmaceuticals Announces Presentation of Forodesine Data at the 45th Annual Meeting of the American Society of Clinical Oncology
8. BioCryst Reports Second Quarter 2009 Financial Results And Provides Corporate Update
9. BioCryst Executives to Present at Two Investor Conferences
10. BioCryst Announces Partnerships for Peramivir for Influenza Outside the U.S.
11. BioCryst to Present at UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... have been hospitalized for a burn as a child experience ... to new research at the University of Adelaide . ... been conducted by the University,s Centre for Traumatic Stress Studies. ... some form of mental illness and 30% suffered depression at ... in the journal Burns , also found ...
(Date:8/29/2014)... disease outbreaks across the Arabian Peninsula and spread to ... the lives of several hundred people since its discovery ... puzzled over how easily the pathogen spreads from human ... virologists from the University of Bonn have now come ... of human transmission is low. Still, a third of ...
(Date:8/29/2014)... As a chiropractic physician and medical doctor an ... direct connection between the condition of the feet and ... shoe inserts and orthotics weren’t satisfying my patients, I ... said. , Customizable to a user’s needs, the patent-pending ... in order to help prevent pain in the foot, ...
(Date:8/29/2014)... HealthDay Reporter , THURSDAY, Aug. 28, ... days of the Ebola outbreak in West Africa has given ... Researchers report in the Aug. 28 online issue of ... The Ebola strains responsible for the current outbreak ... first recorded outbreak of Ebola in central Africa in 1976. ...
(Date:8/29/2014)... (HealthDay News) -- The way that parents respond to ... a new study suggests. Over six months, researchers ... during free play. The sessions were 30 minutes long ... months old at the start of the study. ... infants began to form complex sounds. The babies whose ...
Breaking Medicine News(10 mins):Health News:Intervention needed for survivors of childhood burns 2Health News:MERS: Low transmissibility, dangerous illness 2Health News:MERS: Low transmissibility, dangerous illness 3Health News:Gene Research Yields Insights Into Ebola Virus 2Health News:Gene Research Yields Insights Into Ebola Virus 3Health News:Encouraging Your Baby's Babbling May Speed Language Development 2
... Center researchers have discovered that bortezomib, a promising cancer ... tumor cells by revving up the action of a ... suggest a novel treatment strategy that might someday prove ... into overdrive, so that they self-destruct. , The U-M ...
... 20 SyntheMed, Inc. (OTC,Bulletin Board: SYMD), a biomaterials ... drug delivery products, today,announced that President and CEO Robert ... Fourth Annual Healthcare Conference at the Palace,Hotel in New ... p.m. EST. Lazard Capital Markets will host a ...
... Again: MAGNETOM Verio Brings High-, Resolution MRI ... Delivers the Newest Technology ... 20 Siemens Medical,Solutions (http://www.usa.siemens.com/medical ) is once ... services with the introduction of two,new magnetic resonance imaging ...
... KILLING US with cancers of the prostate, ... kidney, bone, etc? by Randall Dale Chipkar, MISSISSAUGA, ... motorcyclists to protect themselves. In his just released book,MOTORCYCLE ... He asks, "Are unsuspecting riders at risk for cancer,development ...
... protein albumin suggests worsening coronary artery disease, study finds ... small amount of a protein called albumin in the ... their risk of cardiovascular death, say U.S. researchers. , ... age 50 and older, with stable coronary artery disease ...
... ATSI ), manufacturer and marketer of state-of-the-art cardiac,surgery products ... the,19th Annual Piper Jaffray Health Care Conference at the ... 2007, at 8:30 a.m. Eastern Time.,Michael Dale, President and ... Company,s historical financial results and overall business strategy. ...
Cached Medicine News:Health News:Cancer drug works by overactivating cancer gene 2Health News:Cancer drug works by overactivating cancer gene 3Health News:A Magnetic Presence: Siemens New MRI Systems Pulling More Patients Toward the Benefits of MR Imaging 2Health News:A Magnetic Presence: Siemens New MRI Systems Pulling More Patients Toward the Benefits of MR Imaging 3Health News:A Magnetic Presence: Siemens New MRI Systems Pulling More Patients Toward the Benefits of MR Imaging 4Health News:A Magnetic Presence: Siemens New MRI Systems Pulling More Patients Toward the Benefits of MR Imaging 5Health News:A Magnetic Presence: Siemens New MRI Systems Pulling More Patients Toward the Benefits of MR Imaging 6Health News:New Book Links Motorcycle Radiation to Cancer Risk 2Health News:Urine Test Results Can Point to Heart Dangers 2Health News:ATS Medical to Present at the 19th Annual Piper Jaffray Health Care Conference 2
(Date:8/29/2014)... Pa. , Aug. 29, 2014  Unilife Corporation ... UNS) announced today that it intends to release its ... year ended June 30, 2014 after market trading ends ... has scheduled a conference call for 4:30 p.m. U.S. ... 2014 at 6:30 a.m. AEST), to review the Company,s financial ...
(Date:8/29/2014)... PASO ROBLES, Calif. , Aug. 29, 2014 /PRNewswire/ ... launch of its new website design . The ... an overhaul that showcases the company,s new services and ... By implementing a new streamlined design, viewers can ... deliver metrics for health care practices and create a ...
(Date:8/29/2014)... , Aug. 29, 2014 /PRNewswire/ –  ... PHG AEX: PHIA) today announced ... Society of Cardiology (ESC) Congress 2014 ... range of its cardiology solutions serving clinicians and ... prevention and diagnosis, to treatment, ...
Breaking Medicine Technology:Unilife Corporation to Announce Financial Results for Fiscal Year 2014 Fourth Quarter and Year End on Tuesday, September 9, 2014 2PMDS Announces New Website 2Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 2Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 3Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 4Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 5
... FRANKLIN LAKES, N.J., Nov. 3, 2010 BD (Becton, Dickinson ... medical technology company, today reported quarterly revenues of $1.873 billion ... an increase of 1.0 percent from the prior-year period, or ... For the full fiscal year ended September 30, 2010, BD ...
... EATONTOWN, N.J., Nov. 3, 2010 Osteotech, Inc. (Nasdaq: ... field of biologic products for regenerative healing, announced today ... has been selected to receive the Research and Development ... Award in the medical category.  Osteotech was chosen from ...
Cached Medicine Technology:BD Announces Results for 2010 Fourth Fiscal Quarter and Full Year 2BD Announces Results for 2010 Fourth Fiscal Quarter and Full Year 3BD Announces Results for 2010 Fourth Fiscal Quarter and Full Year 4BD Announces Results for 2010 Fourth Fiscal Quarter and Full Year 5BD Announces Results for 2010 Fourth Fiscal Quarter and Full Year 6BD Announces Results for 2010 Fourth Fiscal Quarter and Full Year 7BD Announces Results for 2010 Fourth Fiscal Quarter and Full Year 8BD Announces Results for 2010 Fourth Fiscal Quarter and Full Year 9BD Announces Results for 2010 Fourth Fiscal Quarter and Full Year 10BD Announces Results for 2010 Fourth Fiscal Quarter and Full Year 11BD Announces Results for 2010 Fourth Fiscal Quarter and Full Year 12BD Announces Results for 2010 Fourth Fiscal Quarter and Full Year 13BD Announces Results for 2010 Fourth Fiscal Quarter and Full Year 14BD Announces Results for 2010 Fourth Fiscal Quarter and Full Year 15BD Announces Results for 2010 Fourth Fiscal Quarter and Full Year 16BD Announces Results for 2010 Fourth Fiscal Quarter and Full Year 17Osteotech's Plexur M® Technology Wins Thomas Alva Edison Patent Award from the New Jersey Research and Development Council 2Osteotech's Plexur M® Technology Wins Thomas Alva Edison Patent Award from the New Jersey Research and Development Council 3
... 500 Power Supply is designed ... offers extensive programming capabilities, including ... methods for you to set ... simple, intuitive PowerEase® interface is ...
... The PowerEase® 500 Power ... mini-gel electrophoresis. It offers extensive ... and four custom methods for ... own preferences. The simple intuitive ...
... These modified battery chargers ... supplies for GENIE blotters. ... produce very specific voltages, ... than laboratory power supplies. ...
PS2A200 Power supply is a high current power supply ideal for all types of electrophoresis blotting and short electrophoresis runs....
Medicine Products: